The drug is used for treatment of infectious diseases such as community acquired pneumonia, exacerbation of chronic bronchitis, acute sinusitis, pharyngitis and skin infections. The active ingredient in Omnicef is cefdinir—a semi-synthetic cephalosporin broad-spectrum antibiotic of the third generation for oral administration. Like other cephalosporin antibiotics, cefdinir has a bactericidal action against susceptible organisms through the inhibition of synthesis of bacteria peptidoglycan cell walls by interfering with the final stage of transamination, required for cross-linking.
Your order will be packed safe and secure and dispatched within 24 hours. This is exactly how your parcel will look like (pictures of a real shipping item). It has a size and a look of a regular private letter (9.4x4.3x0.3 inches or 24x11x0.7cm) and it does not disclose its contents
Omnicef Product Description
Omnicef is a cephalosporin antibiotic, used to treat mild to moderate infections in infants, children and adults. Omnicef oral suspension is recommended to be used in infants aged above 6 months, and children under 12 years old for treatment of bacterial infections.
Oral antibiotic Omnicef is characterized by antibacterial action against pathogens, such as:
- Haemophilus influenzae (Hi)
- Haemophilus parainfluenzae (Hpi)
- Moraxella (Branhamella) catarrhalis
- Staphylococcus aureus (S. aureus)
- Streptococcus pneumoniae (pneumococcus)
- Streptococcus pyogenes (S. pyogenes)
Omnicef is effective in treatment of various infectious diseases, including:
- acute maxillary sinusitis*
- tonsillitis and pharyngitis**
- acute otitis media (AOM)***
- community-acquired pneumonia (CAP)*
- acute exacerbations of chronic bronchitis (AECB)*
- uncomplicated skin and skin structure infections (uSSSIs)**
* In patients aged above 13 years (inclusive)
** In patients aged above 6 months
*** In patients aged from 6 months to 12 years (inclusive)
The standard dose of Omnicef for adults is 600mg. The recommended dose of Omnicef for newborns and children under 12 years of age is 14mg per day per kg of the child’s body weight, but not more than 600mg per day. The maximum recommended duration of the antibiotic therapy with Omnicef is 10 days.
In case you’ve missed a dose of Omnicef, skip the tablet if it is almost time for the next dose of this antibiotic. In other case, use the dose of Omnicef as soon as it is possible.
For treatment of uSSSIs and CAP in adults and uSSSIs in children, the total daily Omnicef dose should be divided into two intakes. For the treatment of other bacterial infections in children and adults, the daily dose of Omnicef should be taken as a single one.
Store Omnicef at temperature below 25°C. It is recommended to keep this antibiotic away from moisture, heat and light. Keep capsules Omnicef out of the reach of children.
Omnicef Safety Information
Cephalosporin antibiotics (including Omnicef) may cause serious allergic reactions and increase the risk of gastrointestinal infections. In case of symptoms of serious allergies or severe gastrointestinal reactions, the application of Omnicef capsules or oral suspension should be stopped.
All the material about bacterial infections, published in the review of Omnicef capsules, is for information only and should not be construed to replace the professional medical advice or consultation of the primary care specialist. The online pharmacy takes no responsibility for the damage or loss of any kind, which could happened from using the information about antibiotic Omnicef.
Omnicef Side Effects
Mostly Omnicef is reported to cause mild common adverse events, which intensity can be reduced at decreasing doses or after withdrawal of the antibiotic. Most often, the patients taking Omnicef complain about gastrointestinal adverse events, such as nausea, diarrhea, dyspepsia, abdominal pain or vomiting. Besides, Omnicef may cause other adverse events, including leukopenia, hyperkinesia and rash. In women, this antibiotic may cause vaginitis or vaginal moniliasis.